Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazem Atassi

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Annals of Neurology|May 10, 2018
Integrated magnetic resonance imaging and [<sup>11</sup> C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosisMohamad J Alshikho, Nicole R Zürcher, Marco L Loggia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET RadioligandsDonatienne Van Weehaeghe, Suma Babu, Joke De Vocht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Pseudoreference Regions for Glial Imaging with <sup>11</sup>C-PBR28: Investigation in 2 Clinical CohortsDaniel S Albrecht, Marc D Normandin, Sergey Shcherbinin, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2016
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional PopulationChristina N Fournier, Alyssa Murphy, Lorena Loci, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Neuroimage. Clinical|November 22, 2017
Imaging of glia activation in people with primary lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Nicole R Zürcher, et al.
Muscle & Nerve|June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidenceAmanda M Dios, Suma Babu, Eric J Granucci, et al.
Neuroimage. Clinical|September 22, 2022
Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosisRobert L Barry, Angel Torrado-Carvajal, John E Kirsch, et al.
Neurology|July 1, 2016
Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trialsJonathan D Glass, Vicki S Hertzberg, Nicholas M Boulis, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Annals of Neurology|May 10, 2018
Integrated magnetic resonance imaging and [<sup>11</sup> C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosisMohamad J Alshikho, Nicole R Zürcher, Marco L Loggia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET RadioligandsDonatienne Van Weehaeghe, Suma Babu, Joke De Vocht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Pseudoreference Regions for Glial Imaging with <sup>11</sup>C-PBR28: Investigation in 2 Clinical CohortsDaniel S Albrecht, Marc D Normandin, Sergey Shcherbinin, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2016
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional PopulationChristina N Fournier, Alyssa Murphy, Lorena Loci, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Neuroimage. Clinical|November 22, 2017
Imaging of glia activation in people with primary lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Nicole R Zürcher, et al.
Muscle & Nerve|June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidenceAmanda M Dios, Suma Babu, Eric J Granucci, et al.
Neuroimage. Clinical|September 22, 2022
Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosisRobert L Barry, Angel Torrado-Carvajal, John E Kirsch, et al.
Neurology|July 1, 2016
Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trialsJonathan D Glass, Vicki S Hertzberg, Nicholas M Boulis, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Pageof 8